Parallel import is a possible solution for providing patients in case of shortage or absence of medicines. The most common reasons for drug shorages are marketing, manufacturing problems and dropping out of the manufacturer’s nomenclature, BDA reports. On BAMPTD platform 640 signals were received, 65% due to import rhythms were disturbed, and 22% were due to deregistered products, which generates serious market discrepancies and imposes difficulties for patients.
